Sign in

CIK 0001850119 · <br>Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
842040295
Phone
215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale SVP Finance & Operations sold 4,904 shares at $0.62 ($3,050)
  8. 4 Open-market sale Chief Operations Officer sold 552 shares at $0.62 ($343)
  9. 4 Open-market sale President and CEO sold 475 shares at $0.62 ($295)
  10. 4 Open-market sale See Remarks sold 526 shares at $0.62 ($327)
  11. 4 Open-market sale President and CEO sold 29,552 shares at $0.55 ($16,135)
  12. 4 Open-market sale Chief Operations Officer sold 1,024 shares at $0.55 ($563)
  13. 4 Open-market sale SVP Finance & Operations sold 295 shares at $0.55 ($162)
  14. 4 Grant or award Chief Finanical Officer acquired 19,500 shares (grant or award)
  15. 4 Grant or award Chief Scientific Officer acquired 19,500 shares (grant or award)
  16. 4 Open-market sale President and CEO sold 2,235 shares at $0.62 ($1,375)
  17. 4 Open-market sale See Remarks sold 2,360 shares at $0.62 ($1,451)
  18. 4 Open-market sale Chief Operations Officer sold 2,359 shares at $0.62 ($1,451)
  19. 4 Open-market sale SVP Finance & Operations sold 1,240 shares at $0.62 ($763)
  20. 4 Open-market sale President and CEO sold 34,712 shares at $0.78 ($27,179)

Page 4 of 10 · 188 filings